Characteristics | Community-acquired-ILI | Hospital-acquired-ILI |
---|---|---|
n = 81 | n = 34 | |
Gender: men/women | 23/58 | 9/25 |
Median age (range, years) | 88 (69–103) | 88 (77–99) |
Vaccination against influenza | ||
During the ILI season | 45 (55.6%) | 22 (64.7%) |
Every season | 42 (51.9%) | 19 (55.9%) |
Symptoms | ||
Fever > 37.8°C | 47 (73.7%)* | 23 (67.6%) |
Cough | 69 (85.2%) | 30 (88.2%) |
Sore throat | 10 (12.3%) | 5 (14.7%) |
Length of stay (range, days) | 6 (1–33) | 8 (2–53) |
Reason of admission | ||
Cardio respiratory disease without fever | 39 (48.2%) | 18 (52.9%) |
Infectious disease with fever | 34 (42.0%) | 2 (5.9%) |
Fall or confusion | 16 (19.8%) | 9 (26.5%) |
Other | 14 (17.3%) | 10 (29.4%) |
Treatment against ILI | ||
Antipyretics | 49 (60.5%) | 21 (61.8%) |
Antibiotics | 75 (92.6%) | 23 (67.6%) |
Antiviral treament | 0 (0%) | 0 (0%) |
Lab results | ||
Influenza | 17 (21.0%) | 6 (17.6%) |
Respiratory Syntytial Virus (RVS) | 5 (6.2%) | 0 (0%) |
Influenza and RVS coinfection | 1 (1.2%) | 0 (0%) |
Rhinovirus | 3 (3.7%) | 1 (2.9%) |
Herpes Simplex Virus (HSV) | 1 (1.2%) | 0 (0%) |
Parainfluenzae | 1(1.2%) | 0 (0%) |
No detected virus | 53 (65.4%) | 27 (79.4%) |
Complications | ||
Cardiac | 3 (3.7%) | 0 (0%) |
Respiratory | 6 (7.4%) | 1 (2.9%) |
Death | 5 (6.2%) | 4 (4.8%) |